| scholarly article | Q13442814 |
| P2093 | author name string | Martin Werner | |
| Silke Lassmann | |||
| Christiane Fichter | |||
| Lucas Spohn | |||
| P2860 | cites work | Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis. | Q27851584 |
| Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells | Q33864179 | ||
| Nuclear trafficking of the epidermal growth factor receptor family membrane proteins | Q33998459 | ||
| ErbB receptors: new insights on mechanisms and biology | Q34579265 | ||
| Genome-wide analysis of STAT target genes: elucidating the mechanism of STAT-mediated oncogenesis | Q35946736 | ||
| Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family | Q36162605 | ||
| Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma | Q36755676 | ||
| Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression | Q36798731 | ||
| STAT-mediated EGFR signaling in cancer. | Q36895477 | ||
| Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking | Q37074180 | ||
| Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer | Q37282661 | ||
| Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors | Q37622619 | ||
| Emerging tyrosine kinase inhibitors for esophageal cancer | Q38110962 | ||
| EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer | Q38392935 | ||
| Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie | Q38416059 | ||
| Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine | Q38881033 | ||
| ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways | Q38968846 | ||
| STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas. | Q39115912 | ||
| STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases | Q40272375 | ||
| Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy | Q41859828 | ||
| Control of EGF receptor signaling by clathrin-mediated endocytosis. | Q45345953 | ||
| Out of breath, asleep at the wheel | Q48481760 | ||
| Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE). | Q53754804 | ||
| Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis. | Q54699349 | ||
| Esophageal Cancer | Q56209683 | ||
| Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma | Q95788188 | ||
| P433 | issue | 1 | |
| P921 | main subject | esophageal carcinoma | Q18553999 |
| P304 | page(s) | 41-47 | |
| P577 | publication date | 2015-11-18 | |
| P1433 | published in | Journal of Cell Communication and Signaling | Q26841964 |
| P1476 | title | Subcellular localization of EGFR in esophageal carcinoma cell lines | |
| P478 | volume | 10 |
Search more.